BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31910445)

  • 1. Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe's national antiretroviral therapy programme between 2012 and 2015.
    Makurumidze R; Mutasa-Apollo T; Decroo T; Choto RC; Takarinda KC; Dzangare J; Lynen L; Van Damme W; Hakim J; Magure T; Mugurungi O; Rusakaniko S
    PLoS One; 2020; 15(1):e0222309. PubMed ID: 31910445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of reported retention in antiretroviral therapy after roll-out to peripheral facilities in Mozambique: Results of a retrospective national cohort analysis.
    Lafort Y; Couto A; Sunderbrink U; Hoek R; Shargie E; Zhao J; Viisainen K; Simwaka B
    PLoS One; 2018; 13(6):e0198916. PubMed ID: 29927961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient retention, clinical outcomes and attrition-associated factors of HIV-infected patients enrolled in Zimbabwe's National Antiretroviral Therapy Programme, 2007-2010.
    Mutasa-Apollo T; Shiraishi RW; Takarinda KC; Dzangare J; Mugurungi O; Murungu J; Abdul-Quader A; Woodfill CJ
    PLoS One; 2014; 9(1):e86305. PubMed ID: 24489714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-mix, programmatic characteristics, retention and predictors of attrition among patients starting antiretroviral therapy (ART) before and after the implementation of HIV "Treat All" in Zimbabwe.
    Makurumidze R; Buyze J; Decroo T; Lynen L; de Rooij M; Mataranyika T; Sithole N; Takarinda KC; Apollo T; Hakim J; Van Damme W; Rusakaniko S
    PLoS One; 2020; 15(10):e0240865. PubMed ID: 33075094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with long-term antiretroviral therapy attrition among adolescents in rural Uganda: a retrospective study.
    Okoboi S; Ssali L; Yansaneh AI; Bakanda C; Birungi J; Nantume S; Okullu JL; Sharp AR; Moore DM; Kalibala S
    J Int AIDS Soc; 2016; 19(5 Suppl 4):20841. PubMed ID: 27443271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012.
    Dalhatu I; Onotu D; Odafe S; Abiri O; Debem H; Agolory S; Shiraishi RW; Auld AF; Swaminathan M; Dokubo K; Ngige E; Asadu C; Abatta E; Ellerbrock TV
    PLoS One; 2016; 11(11):e0165528. PubMed ID: 27829033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons for test and treat in an antiretroviral programme after decentralisation in Uganda: a retrospective analysis of outcomes in public healthcare facilities within the Lablite project.
    Kiwuwa-Muyingo S; Abongomera G; Mambule I; Senjovu D; Katabira E; Kityo C; Gibb DM; Ford D; Seeley J
    Int Health; 2020 Sep; 12(5):429-443. PubMed ID: 31730168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community adherence support improves programme retention in children on antiretroviral treatment: a multicentre cohort study in South Africa.
    Grimwood A; Fatti G; Mothibi E; Malahlela M; Shea J; Eley B
    J Int AIDS Soc; 2012 May; 15(2):17381. PubMed ID: 22713255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retention and risk factors for attrition among adults in antiretroviral treatment programmes in Tanzania, Uganda and Zambia.
    Koole O; Tsui S; Wabwire-Mangen F; Kwesigabo G; Menten J; Mulenga M; Auld A; Agolory S; Mukadi YD; Colebunders R; Bangsberg DR; van Praag E; Torpey K; Williams S; Kaplan J; Zee A; Denison J
    Trop Med Int Health; 2014 Dec; 19(12):1397-410. PubMed ID: 25227621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003-2015).
    Mutanga JN; Mutembo S; Ezeamama AE; Song X; Fubisha RC; Mutesu-Kapembwa K; Sialondwe D; Simuchembu B; Chinyonga J; Thuma PE; Whalen CC
    BMC Public Health; 2019 Aug; 19(1):1120. PubMed ID: 31416432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retention of HIV infected pregnant and breastfeeding women on option B+ in Gomba District, Uganda: a retrospective cohort study.
    Kiwanuka G; Kiwanuka N; Muneza F; Nabirye J; Oporia F; Odikro MA; Castelnuovo B; Wanyenze RK
    BMC Infect Dis; 2018 Oct; 18(1):533. PubMed ID: 30355356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and predictors of attrition from antiretroviral care among adults in a rural HIV clinic in Coastal Kenya: a retrospective cohort study.
    Hassan AS; Mwaringa SM; Ndirangu KK; Sanders EJ; de Wit TF; Berkley JA
    BMC Public Health; 2015 May; 15():478. PubMed ID: 25957077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates and predictors of attrition among children on antiretroviral therapy in Ethiopia: A prospective cohort study.
    Biru M; Hallström I; Lundqvist P; Jerene D
    PLoS One; 2018; 13(2):e0189777. PubMed ID: 29408897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival outcomes of HIV infected children receiving antiretroviral therapy: an observational study from Zambia (2003-2015).
    Mutanga JN; Mutembo S; Ezeamama AE; Song X; Fubisha RC; Mutesu-Kapembwa K; Sialondwe D; Simuchembu B; Chinyonga J; Thuma PE; Whalen CC
    BMC Public Health; 2019 Jan; 19(1):115. PubMed ID: 30691416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attrition in HIV care following HIV diagnosis: a comparison of the pre-UTT and UTT eras in South Africa.
    Onoya D; Hendrickson C; Sineke T; Maskew M; Long L; Bor J; Fox MP
    J Int AIDS Soc; 2021 Feb; 24(2):e25652. PubMed ID: 33605061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival probability and factors associated with time to loss to follow-up and mortality among patients on antiretroviral treatment in central Kenya.
    Wekesa P; McLigeyo A; Owuor K; Mwangi J; Ngugi E
    BMC Infect Dis; 2022 Jun; 22(1):522. PubMed ID: 35668350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender-related differences in outcomes and attrition on antiretroviral treatment among an HIV-infected patient cohort in Zimbabwe: 2007-2010.
    Takarinda KC; Harries AD; Shiraishi RW; Mutasa-Apollo T; Abdul-Quader A; Mugurungi O
    Int J Infect Dis; 2015 Jan; 30():98-105. PubMed ID: 25462184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pattern of attrition from an antiretroviral treatment program in Nigeria.
    Odafe S; Torpey K; Khamofu H; Ogbanufe O; Oladele EA; Kuti O; Adedokun O; Badru T; Okechukwu E; Chabikuli O
    PLoS One; 2012; 7(12):e51254. PubMed ID: 23272094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
    Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
    PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.